Partial-onset Seizures
📧 Sign up to get email alerts when something new happens for Partial-onset Seizures.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy [Phase 3]
A Phase 3 trial evaluating retigabine for partial-onset refractory seizures in epilepsy has completed, with efficacy and safety results post…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy [Phase 3]
A Phase 3 trial evaluating retigabine as adjunctive therapy for partial-onset seizures in epilepsy has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]
Results from a Phase 3 long-term safety study of lacosamide in adults with partial-onset seizures.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy [Phase 3]
This Phase 3 study assessed the effectiveness and safety of topiramate in children with epilepsy and has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures [Phase 2]
A Phase 2 study evaluating the efficacy and safety of adding topiramate to existing therapy in patients with difficult-to-treat partial-onse…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating topiramate as add-on therapy for difficult-to-treat partial-…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. [Phase 2]
Phase 2 trial evaluating the efficacy and safety of add-on topiramate in patients with difficult-to-treat epilepsy and partial-onset seizure…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy [Phase 2]
The Phase 2 study of Topiramate in patients with difficult-to-control epilepsy has completed, reporting on its efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Conversion to Monotherapy Study With Keppra XR for Partial Seizures [Phase 3]
Phase 3 trial evaluating conversion to Keppra XR monotherapy for partial seizures in epilepsy; results from the completed study have been po…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of topiramate as monotherapy for recently diagnosed partial-onset seizures has complet…
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]
Phase 3 trial update reports safety findings for intravenous lacosamide followed by twice-daily oral lacosamide in adults with partial-onset…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures [Phase 3]
Long-term follow-up study evaluating the safety and efficacy of levetiracetam in children with partial-onset seizures (Phase 3).